Podcast: key readouts from ESC and ERS
It's conference season again. In this episode, the healthcare team rounds up the latest readouts and emerging themes from two…
Features
Osaka has the science. Now it needs the business
Peptide innovator says the drug class is due for a rethink
MSD’s Lipfendra takes on injectable rivals for cholesterol-lowering market supremacy
MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones
A strategic shift for gene therapies: manufacturing and market size take centre stage
Health tech’s role in obesity to expand beyond a ‘nice-to-have’
Orexin receptor agonists set to propel narcolepsy treatment into a new era
